Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 42, Issue , 2013, Pages 122-134

  Das, Undurti N ^a,b,c  

^a UND LIFE SCIENCES   (United States)

^b GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Cytokines; Dopamine; Interleukin; Long chain polyunsaturated fatty acids; Neuroprotection; Schizophrenia

Indexed keywords

ACYL COENZYME A DESATURASE; CD59 ANTIGEN; ESSENTIAL FATTY ACID; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LIPOXIN; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN DEVELOPMENT; BRAIN GROWTH; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FATTY ACID METABOLISM; HUMAN; MOLECULAR PATHOLOGY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; PRENATAL PERIOD; SCHIZOPHRENIA; SUPPLEMENTATION; VIRUS INFECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CYTOKINES; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; HUMANS; SCHIZOPHRENIA;

EID: 84873523145     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.06.010     Document Type: Article

References (156)

1. Aïd S., Vancassel S., Linard A., Lavialle M., Guesnet P. Dietary docosahexaenoic acid [22: 6(n?3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 2005, 135:1008-1013.
2. Albuquerque E.X., Pereira E.F., Mike A., Eisenberg H.M., Maelicke A., Alkondon M. Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance. Behav Brain Res 2000, 113:131-141.
3. Allebeck P., Allgulander C., Henninggsohn I., Jakobsson S.W. Causes of death in a cohort of 50,465 young men-validity of recorded suicide as underlying cause of death. Scand J Soc Med 1991, 19:242-247.
4. Allen N.B., Lewinsphn P.M., Seeley J.R. Prenatal and perinatal influences on risk for psychopathology in childhood and adolescence. Dev Psychopathol 1998, 10:513-529.
5. Almeida T., Cunha R.A., Ribeiro J.A. Facilitation by arachidonic acid of acetylcholine release from the rat hippocampus. Brain Res 1999, 826:104-111.
6. Amore M., Balista C., McCreadie R.G., Cimmino C., Pisani F., Bevilacqua G., et al. Can breast-feeding protect against schizophrenia? Case-control study. Biol Neonate 2003, 83:97-101.
7. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306:879-881.
8. Arai Y., Funatsu N., Numayama-Tsuruta K., Nomura T., Nakamura S., et al. Role of Fabp7, a downstream gene of Pax6, in the maintenance of neuroepithelial cells during early embryonic development of the rat cortex. J Neurosci 2005, 25:9752-9761.
9. Aravindakshan M., Sitasawad S., Debsikdar V., Ghate M., Evans D., Horrobin D.F., et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 2003, 53:56-64.
10. Arnold C., Konkel A., Fischer R., Schunck W.H. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacol Rep 2010, 62:536-547.
11. Assies J., Lieverse R., Vreken P., Wanders R.J., Dinhemans P.M., Linszen D.H. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 2001, 49:510-522.
12. Auestad N., Scott D.T., Janowsky J.S., Jacobsen C., Carroll R.E., Montalto M.B., et al. Visual, cognitive, and language assessments at 39months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1year of age. Pediatrics 2003, 112(3 Pt 1):e177-e183.
13. Baguma-Nibasheka M., Brenna J.T., Nathaniesz P.W. Delay of preterm delivery in sheep by omega-3 long-chain polyunsaturates. Biol Reprod 1999, 60:698-701.
14. Balendiran G.K., Schnutgen F., Scapin G., Borchers T., Xhong N., et al. Crystal structure and thermodynamic analysis of human brain fatty acid binding protein. J Biol Chem 2000, 275:27,045-27,054.
15. Barker D.J.P., Osmond C., Rodin J., Fall C.H.D., Winter P.D. Low weight gain in infancy and suicide in adult life. BMJ 1995, 311:1203.
16. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 2004, 430:419-421.
17. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., Gennarelli M. Association between?G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 2001, 6:79-82.
18. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
19. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 2002, 26:204-211.
20. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
21. Campbell W.B., Fleming I. Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch 2010, 459:881-895.
22. Cansev M., Wurtman R.J., Sakamoto T., Ulus I.H. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement 2008, 4(1 Suppl. 1):S153-S168.
23. Carlson S.E., Werkman S.H., Peeples J.M., Cooke R.J., Tolley E.A. Arachidonic acid status correlates with first year growth in preterm infants. Proc Nat Acad Sci U S A 1993, 90:1073-1077.
24. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HT gene. Science 2003, 301:386-390.
25. Cazzullo C.L., Sacchetti E., Galluzzo A., Adorni A., Pegoraro M., Bosis S., et al. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:33-39.
26. Chandley M.J., Miller M.N., Kwasigroch C.N., Wilson T.D., Miller B.E. Increased antibodies for the alpha7 subunit of the nicotinic receptor in schizophrenia. Schizophr Res 2009, 109:98-101.
27. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci Lett 1996, 220:171-174.
28. Chang M.C., Bell J.M., Purdon A.D., Chikhale E.G., Grange E. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment. Neurochem Res 1999, 24:399-406.
29. Chang M.C., Contreras M.A., Rosenberger T.A., Rintala J.J., Bell J.M., Rapoport S.I. Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J Neurochem 2001, 77:796-803.
30. Chaudhry A., Laychock S.G., Rubin R.P. The effects of fatty acids on phosphoinositide synthesis and myo-inositol accumulation in exocrine pancreas. J Biol Chem 1987, 262:17,426-17,431.
31. Chiang N., Arita M., Serhan C.N. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essen Fatty Acids 2005, 73:163-177.
32. Claria J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci U S A 1995, 92:9475-9479.
33. Crow T.J., Done D.J., Sacker A. Childhood precursors of psychosis as clues to its evolutionary origins. Eur Arch Psychiatry Clin Neurosci 1995, 245:61-69.
34. da Costa K.A., Rai K.S., Craciunescu C.N., Parikh K., Mehedint M.G., Sanders L.M., et al. Dietary docosahexaenoic acid supplementation modulates hippocampal development in the Pemt?/? mouse. J Biol Chem 2010, 285:1008-1015.
35. Darios F., Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006, 440:813-817.
36. Das U.N. Beneficial effect of eicosapentaenoic acid and docosahexaenoic acid in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Essen Fatty Acids 1994, 51:207-213.
37. Das U.N. Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essen Fatty Acids 2001, 65:37-40.
38. Das U.N. The brain-lipid-heart connection. Nutrition 2001, 17:260-263.
39. Das U.N. A perinatal strategy to prevent adult disease: a role for long-chain polyunsaturated fatty acids 2002, Kluwer Academic Publishers, Boston.
40. Das U.N. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essen Fatty Acids 2002, 67:1-12.
41. Das U.N. Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-?, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain Dev 2003, 25:251-261.
42. Das U.N. Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory. Nutrition 2003, 19:62-65.
43. Das U.N. Essential fatty acids: biochemistry, physiology, and pathology. Biotechnology J 2006, 1:420-439.
44. Das U.N. Essential fatty acids-a review. Current Pharmaceutical Biotechnol 2006, 7:467-482.
45. Das U.N. Clinical laboratory tools to diagnose inflammation. Advances in Clinical Chemistry 2006, 41:189-229.
46. Das U.N. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008, 7:37.
47. Das U.N. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease-but how and why?. Prostaglandins Leukot Essent Fatty Acids 2008, 78:11-19.
48. Das U.N. Influence of polyunsaturated fatty acids and their metabolites on stem cell biology. Nutrition 2011, 27:21-25.
49. Das U.N. Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer and metastasis. Cancer Metastasis Rev 2011, 30:311-324.
50. Das U.N., Devi G.R., Rao K.P., Rao M.S. Prostaglandins and their precursors can modify genetic damage induced by benzo(a)pyrene and gamma-radiation. Prostaglandins 1985, 29:911-920.
51. Das U.N., Devi G.R., Rao K.P., Rao M.S. Prostaglandins can modify gamma-radiation and chemical-induced cytotoxicity and genetic damage both in vitro and in vivo. Prostaglandins 1989, 38:689-699.
52. DeGeorge J.J., Ousley A.H., McCarthy K.D., Lapetina E.G., Morell P. Acetylcholine stimulates selective liberation and re-esterification of arachidonate and accumulation of inositol phosphates and glycerophosphoinositol in C62B glioma cells. J Biol Chem 1987, 262:8077-8083.
53. Done D.J., Johnstone E.C., Frith C.D., et al. Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British Perinatal Mortality Survey. BMJ 1991, 302:1576-1580.
54. Dworkin R.H., Cornblatt B.A., Friedmann R., et al. Childhood precursors of affective vs social deficits in adolescents at risk for schizophrenia. Schizophr Bull 1993, 19:563-577.
55. Ebrinc S., Top C., Oncul O., Basoglu C., Cavuslu S., Cetin M. Serum interlukin 1 alpha and interleukins 2 levels in patients with schizophrenia. J Int Med Res 2002, 30:314-317.
56. Editorial Of mice and mental illness. Nat Neurosci 2003, 6:323.
57. Endres S., Ghorbani R., Kelley V.E., et al. The effect of dietary supplementation with n?3 polyunsaturated fatty acids on the synthesis of interleukins-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.
58. Fricchione G.L., Bilfinger T.V., Stefano G.B. The macrophage and neuropsychiatric disorders. Neurobiol 1996, 9:16-29.
59. Gale C.R., Martyn C.N. Breast feeding, dummy use, and adult intelligence. Lancet 1996, 347:1057.
60. Gangemi S., Luciotti G., D'Urbano E., Mallamace A., Santoro D., Bellinghieri G., et al. Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J Appl Physiol 2003, 94:2237-2240.
61. Gangemi S., Pescara L., D'Urbano E., Basile G., Nicita-Mauro V., Davì G., et al. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol 2005, 40:612-614.
62. Gao L., Yin H., Milne G.L., Porter N.A., Morrow J.D. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 2006, 281:14,092-14,099.
63. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., et al. Serotonin A1 receptor acts during development to establish normal anxiety-like behavior in the adult. Nature 2002, 416:396-400.
64. Guan Z.Z., Zhang X., Blennow K., Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 1999, 10:1779-1782.
65. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297:400-403.
66. Hibbeln J.R., Makino K.K., Martin C.E., Dickerson F., Boronow J., Fenton W.S. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry 2003, 53:431-441.
67. Hong S., Gronert K., Devchand P.R., Moussignac R.L., Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003, 278:14,677-14,687.
68. Innis M.S., Owens S.P. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr 2001, 131:118-122.
69. Ishikawa M., Hashimoto K. ?7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia. Curr Pharm Des 2011, 17:121-129.
70. Iwayama Y., Hattori E., Maekawa M., Yamada K., Toyota T., Ohnishi T., et al. Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(2):484-493.
71. Jones P., Rodgers B., Murray R., et al. Child developmental risk factors for schizophrenia in the 1946 birth cohort. Lancet 1994, 344:1398-1402.
72. Jones P.B., Rantakallio P., Hartikainen A.L., Isohanni M., Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. Am J Psychiatry 1998, 155:355-364.
73. Joy C.B., Mumby-Croft R., Joy L.A. Polyunsaturated fatty acid (fish oil or evening primrose oil) for schizophrenia. Cochrane Database Syst Rev 2000, 2:CD001257.
74. Jung K.H., Song S.U., Yi T., Jeon M.S., Hong S.W., Zheng H.M., et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology 2011, 140:998-1008.
75. Kawakita E., Hashimoto M., Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 139:991-997.
76. Khan M.M., Evans D.R., Gunna V., Scheffer R.E., Parikh V.V., Mahadik S.P. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 2002, 58:1-10.
77. Kim Y.K., Kim L., Lee M.S. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophr Res 2000, 44:165-175.
78. Kim H.-Y., Akbar M., Lau A., Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n?3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000, 275:35,215-35,223.
79. Kim S.H.F., Weeber E.J., Sweatt J.D., Stoll A.L., Marangell L.B. Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry 2001, 6:246-248.
80. Kim H.-Y., Akbar M., Kim K.-Y. Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J Mol Neurosci 2001, 16:223-227.
81. Kinney G.G., Vogel G.W., Feng P. Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res 1997, 756:68-75.
82. Kowalski J., Blada P., Kucia K., Madej A., Herman Z.S. Neuroleptics normalize increased release of interleukins-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr Res 2001, 50:169-175.
83. Kroetz D.L., Zeldin D.C. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 2002, 13:273-283.
84. Kumar S.G., Das U.N. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essen Fatty Acids 1994, 50:331-334.
85. Kumar K.V., Das U.N. Effect of cis-unsaturated fatty acids, prostaglandins, and free radicals on angiotensin-converting enzyme activity in vitro. Proc Soc Exp Biol Med 1997, 214:374-379.
86. Kumar S.G., Das U.N., Kumar K.V., Madhavi N., Das N.P., Tan B.K.H. Effect of n?6 and n?3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutrition Res 1992, 12:815-823.
87. Lattin J.E., Schroder K., Su A.I., Walker J.R., Zhang J., Wiltshire T., et al. Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res 2008, 4:5.
88. Leask S.J., Done D.J., Crow T.J., Richards M., Jones P.B. No association between breast-feeding and adult psychosis in two national birth cohorts. Br J Psychiatry 2000, 177:218-221.
89. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation signals in resolution. Nat Immunol 2001, 2:612-619.
90. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997, 277:1659-1662.
91. Livingstone P.D., Srinivasan J., Kew J.N., Dawson L.A., Gotti C., Moretti M., et al. Alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci 2009, 29:539-550.
92. Lonergan P.E., Martin D.S.D., Horrobin D.F., Lynch M.A. Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to ?-radiation. J Biol Chem 2002, 277:20,804-20,811.
93. Lucas A., Morley R., Cole T.J., et al. Breast milk and subsequent intelligence quotient in children born pre-term. Lancet 1992, 239:261-264.
94. Maekawa M., Takashima N., Matsumata M., Ikegami S., Kontani M., Hara Y., et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 2009, 4:e5085.
95. Maes M., Bocchio Chiavetto L., Bignotti S., Battisa Tura G.J., Pioli R., Boin F., et al. Increased serum interleukins-8 and interleukins-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 2002, 54:281-291.
96. Mahadik S.P., Evans D., Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:463-493.
97. Makrides M., Neumann M., Simmer K., Pater J., Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?. Lancet 1995, 345:1463-1468.
98. Malloy M.H., Berendes H. Does breast feeding influence intelligence quotients at 9 and 10years of age. Early Hum Dev 1998, 50:209-217.
99. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronet K., Musto A., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003, 278:43,807-43,817.
100. Martin D.S.D., Lonergan P.E., Boland B., Fogarty M.P., Brady M., Horrobin D.F., et al. Apoptotic changes in the aged brain are triggered by interleukin-1?-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J Biol Chem 2002, 277:34,239-34,246.
101. Marx C.E., Jarskog L.F., Lauder J.M., Lieberman J.A., Gilmore J.H. Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 2001, 50:743-749.
102. McAllister C.G., van Kammen D.P., Rehn T.J., Miller A.L., Gurklis J., Kelley M.E., et al. Increases in CSF levels of interleukins-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 1995, 152:1291-1297.
103. McCreadie R.G. The Nothsdale Schizophrenia Surveys. 16. Breast-feeding and schizophrenia: preliminary results and hypotheses. Br J Psychiatry 1997, 170:334-337.
104. Merry R.J. Oxidative stress and mitochondrial function with aging-the effects of calorie restriction. Aging Cell 2004, 3:7-12.
105. Milligan G., Stoddart L.A., Brown A.J. G protein-coupled receptors for free fatty acids. Cell Signal 2006, 18:1360-1365.
106. Mitsumori T., Furuyashiki T., Momiyama T., Nishi A., Shuto T., Hayakawa T., et al. Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake. Eur J Neurosci 2011, 34:594-604.
107. Mittendorfer-Rutz E., Rasmussen F., Wasserman D. Restricted fetal growth and adverse maternal psychosocial and socioeconomic conditions as risk factors for suicidal behaviour of offspring: a cohort study. Lancet 2004, 364:1135-1140.
108. Neugebauer R., Reuss M.L. Association of maternal, antenatal and perinatal complications with suicide in adolescence and young adulthood. Acta Psychiatr Scand 1998, 97:412-418.
109. Neugebauer R., Hoek H.W., Susser E. Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood. JAMA 1999, 282:455-462.
110. Nilsson P.M., Nyberg P., Ostergren P.O. Increased susceptibility to stress at a psychological assessment of stress tolerance is associated with impaired fetal growth. Int J Epidemiol 2001, 30:75-80.
111. Nishizaki T., Nomura T., Matsuoka T., Enikolopov G., Sumikawa K. Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Brain Res Mol Brain Res 1999, 69:263-272.
112. Nithipatikom K., Gross G.J. Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection. J Cardiovasc Pharmacol Ther 2010, 15:112-119.
113. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
114. Olsen S.F., Olsen J., Frische G. Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int J Epidemiol 1990, 19:971-977.
115. Oquendo M.A., Baca-Garcia E. Nurture versus nature: evidence of intrauterine effects on suicidal behaviour. Lancet 2004, 364:1102-1104.
116. Owada Y., Abdelwahab S.A., Kitanaka N., Sakagami H., Takano H., et al. Altered emotional behavioral responses in mice lacking brain-type fatty acid binding protein gene. Eur J Neurosci 2006, 24:175-187.
117. Owens S.P., Innis S.M. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linolenic and a-linolenic acid deficient diet in formula-fed piglets. J Nutr 1999, 129:2088-2093.
118. Pavlov V.A., Tracey K.J. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci 2004, 61:2322-2331.
119. Peet M., Poole J., Laugharne J. Infant feeding and the development of schizophrenia. Schizophrenia Res 1997, 24:255-256.
120. Peet M., Brind J., Ramchand C.N., Shah S., Vankar G.K. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res 2001, 49:243-251.
121. Peet M., Horrobin D.F. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 2002, 36:7-18. E-E Multicentre Study Group.
122. Perl O., Ilani T., Strous R.D., Lapidus R., Fuchs S. The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J 2003, 17:1948-1950.
123. Perl O., Strous R.D., Dranikov A., Chen R., Fuchs S. Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity. Neuropsychobiology 2006, 53:88-93.
124. Pinchasi I., Burstein M., Michaelson D.M. Metabolism of arachidonic acid and prostaglandins in the Torpedo electric organ: modulation by the presynaptic muscarinic acetylcholine receptor. Neuroscience 1984, 13:1359-1364.
125. Puri B.K., Richardson A.J., Horrobin D.F., Easton T., Saeed N., Oatridge A., et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalization of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int J Clin Pract 2000, 54:57-63.
126. Reddy R.D., Keshavan M.S., Yao J.K. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull 2004, 30:901-911.
127. Reichman M., Nen W., Hokin L.E. Acetylcholine releases prostaglandins from brain slices incubated in vitro. J Neurochem 1987, 49:1216-1221.
128. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 2006, 11:514-522.
129. Reseland J.E., Haugen F., Hollung K., Solvoll K., Halvorsen B., Brude I.R., et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001, 42:743-750.
130. Romano M., Luciotti G., Gangemi S., Marinucci F., Prontera C., D'Urbano E., et al. Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Lab Invest 2002, 82:1253-1254.
131. Ross B.M., Seguin J., Sieswerda L.E. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?. Lipids Health Dis 2007, 6:21.
132. Rumajogee P., Verge D., Hanoun N., Brisorgueil M.J., Hen R., Lesch K.P., et al. Phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and camp. Eur J Neurosci 2004, 19:937-944.
133. Salk L., Lipsitt L.P., Sturner W.Q., Reilly B.M., Levat R.H. Relationship of maternal and perinatal conditions to eventual adolescent suicide. Lancet 1985, 1:624-627.
134. Sasaki T., Okazaki Y., Akaho R., et al. Type of feeding during infancy and later development of schizophrenia. Schizophr Res 2000, 42:79-82.
135. Serhan C.N. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005, 73:141-162.
136. Serhan C.N., Maddox J.F., Petasis N.A., Akritopoulou-Zanze I., Papayianni A., Brady H.R., et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 1995, 34:14,609-14,615.
137. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000, 192:1197-1204.
138. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Gronert K., Chiang N. Anti-microinflammatory lipid signals generated from dietary N?3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N?3 PUFA therapeutic actions. J Physiol Pharmacol 2000, 51(4 Pt 1):643-654.
139. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammatory signals. J Exp Med 2002, 196:1025-1037.
140. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23:297-302.
141. Shimamoto C., Nakanishi Y., Katsu K., Nakano T., Kubota T., Mori H., et al. Prostaglandin E2 release in gastric antral mucosa of guinea-pigs: basal PGE2 release by cyclo-oxygenase 2 and ACh-stimulated PGE2 release by cyclo-oxygenase 1. Exp Physiol 2006, 91:1015-1024.
142. Shivani P., Rao K.P., Chaudhury J.R., Ahmed J., Rao B.R., Kanjilal S., et al. Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot Essen Fatty Acids 2009, 80:43-50.
143. Smythe J.W., Rowe W.B., Meaney M.J. Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Brain Res Dev Brain Res 1994, 80:183-189.
144. Sørensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Breastfeeding and risk of schizophrenia in the Copenhagen Perinatal Cohort. Acta Psychiatr Scand 2005, 112:26-29.
145. Sperling R.I., Benincaso A.I., Knoell C.T., Larkin J.K., Austen K.F., Robinson D.R. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993, 91:651-660.
146. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl) 1998, 136:320-327.
147. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 2007, 27:3663-3676.
148. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
149. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., et al. Nicotinic acetylcholine receptor ?7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
150. Watanabe A., Toyota T., Owada Y., Hayashi T., Iwayama Y., Matsumata M., et al. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol 2007, 5:e297.
151. Waterland R.A., Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr 1999, 69:179-197.
152. Williams R.S.B., Cheng L., Mudge A.W., Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature 2002, 417:292-295.
153. Yang K., Wang X.Q., He Y.S., Lu L., Chen Q.J., Liu J., et al. Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol 2010, 9:66.
154. Zalcman S.S. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res 2002, 944:157-164.
155. Zhang X.Y., Zhou D.F., Zhang P.Y., Wu G.Y., Cao L.Y., Shen Y.C. Elevated interleukins-2, interleukins-6 and interleukins-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 2002, 57:247-258.
156. Zordoky B.N., El-Kadi A.O. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther 2010, 125:446-463.